TPO and autoimmune thrombocytopenic purpura: However, in our study the risk of VE in ITP patients with a history of previous neoplasia while on TPO-RA was disproportional (more than 40-fold increased risk in elderly patients), suggesting a novel association of these variables with VE in elderly ITP patients under TPO-RA therapy.